Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 71: 1518-1522, 1991;
8750-7587/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leipala, J. A.
Right arrow Articles by Packer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leipala, J. A.
Right arrow Articles by Packer, L.

Journal of Applied Physiology, Vol 71, Issue 4 1518-1522, Copyright © 1991 by American Physiological Society

ARTICLES

Protection of the reperfused heart by L-propionylcarnitine

J. A. Leipala, R. Bhatnagar, E. Pineda, S. Najibi, K. Massoumi and L. Packer
Department of Molecular and Cell Biology, University of California, Berkeley 94720.

The effects of L-propionylcarnitine on mechanical function, creatine phosphate and ATP content, and lactate dehydrogenase leakage were studied in isolated perfused rat hearts exposed to global no-flow ischemia for 30 min followed by reperfusion for 20 min. Five and 10 mM L-propionylcarnitine resulted in a 100% recovery of left ventricular-developed pressure, whereas the recovery was only 40% in the hearts perfused without this agent. Ischemia-reperfusion caused a 85% loss of creatine phosphate and a 77% loss of ATP, which was prevented by 10 mM L-propionylcarnitine. Five millimolar L-propionylcarnitine protected the heart from the loss of creatine phosphate but not from the loss of ATP. Ten millimolar L-propionylcarnitine failed to improve the postischemic left ventricular-developed pressure, when it was added to the perfusate only after ischemia. L-propionylcarnitine alleviated the decrease of coronary flow in the reperfused hearts. Lactate dehydrogenase leakage was aggravated in the beginning of the reperfusion period by 10 mM L-propionylcarnitine. This adverse effect was, however, transient. L-Propionylcarnitine provides protection for the postischemic reperfused heart in a dose-dependent manner. The optimal time for administration is before the ischemic insult. High doses of this compound may perturb cell membrane integrity. Moreover, the present data point to an intracellular, metabolic, and perhaps anaplerotic mechanism of action of L-propionylcarnitine in cardiac ischemia-reperfusion injury.


This article has been cited by other articles:


Home page
 MutagenesisHome page
C. L. Garcia, S. Filippi, P. Mosesso, M. Calvani, R. Nicolai, L. Mosconi, and F. Palitti
The protective effect of L-carnitine in peripheral blood human lymphocytes exposed to oxidative agents
Mutagenesis, January 1, 2006; 21(1): 21 - 27.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
W. Zou, S. K. Noh, K. Q. Owen, and S. I. Koo
Dietary L-Carnitine Enhances the Lymphatic Absorption of Fat and {alpha}-Tocopherol in Ovariectomized Rats
J. Nutr., April 1, 2005; 135(4): 753 - 756.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R Lango, R.T Smolenski, M Narkiewicz, J Suchorzewska, and W Lysiak-Szydlowska
Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass
Cardiovasc Res, July 1, 2001; 51(1): 21 - 29.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online